Repeated measurements of different biomarkers over time offer a better risk prediction than single measurements for pulmonary arterial hypertension…
Articles by Patricia Inácio, PhD
Genetic variants close to the SOX17 and the HLA-DPB1 genes are linked to pulmonary arterial hypertension (PAH), according to the findings of…
Pulmonary arterial hypertension (PAH) patients with an enlarged right side of the heart show higher pulmonary arterial pressures and increased…
The severity of pulmonary hypertension (PH) increases the risk of fetus death, although mortality among PH pregnant women is low,…
Idiopathic pulmonary arterial hypertension (IPAH) patients who failed to respond to treatment with Revatio (sildenafil), either alone or combined with other…
More pulmonary arterial hypertension (PAH) patients were able to achieve complete daily inhalations after switching to a more concentrated formulation…
Intravenous treatment with the approved heart failure medicine milrinone leads to significant improvements in heart structure and function in patients with…
An easy and simple tool called the incremental shuttle walk distance test, or ISWD, appears promising to identify early signs…
A new Phase 2 study evaluating Tenax Therapeutic’s investigational levosimendan as a therapy for pulmonary hypertension (PH) associated…
Bellerophon‘s positive top-line results from its Phase 2 trial testing INOpulse as a potential therapy for pulmonary hypertension…
A project investigating the role of a special protein called PFKFB3 in pulmonary hypertension (PH) has been awarded a $2.2…
Bellerophon Therapeutics announced that is moving forward with a planned Phase 2b trial that will investigate INOpulse as…